Aurobindo Pharma declined 1.13% to Rs 1,054.30 after the US drug regulator issued nine observations post inspection at Telangana manufacturing facility of Eugia Pharma Specialities, a wholly owned subsidiary of the company.
| Subscribe To Our Free Newsletter |
